Lehrstuhl für Innere Medizin III

Distinct Metabolism of Bone Marrow Adipocytes and their Role in Bone Metastasis (2022) Li Y, Cao S, Gaculenko A, Zhan Y, Bozec A, Chen X Journal article, Review article Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and in vitro Modeling (2022) Schmidt A, Fuchs M, Stojanović SD, Liang C, Schmidt K, Jung M, Xiao K, et al. Journal article Epithelial HIF2 alpha expression induces intestinal barrier dysfunction and exacerbation of arthritis (2022) Wen J, Lyu P, Stolzer I, Xu J, Gießl A, Lin Z, Andreev D, et al. Journal article Non-invasive metabolic profiling of inflammation in joints and entheses by multispectral optoacoustic tomography (2022) Tascilar K, Fagni F, Kleyer A, Bayat S, Heidemann R, Steiger F, Krönke G, et al. Journal article Automated Bone Density Measurements using Deep Learning (2022) Folle L, Meinderink T, Simon D, Liphardt AM, Thies M, Krönke G, Schett G, et al. Conference contribution, Abstract of a poster A Yoga Exercise App Designed for Patients With Axial Spondylarthritis: Development and User Experience Study (2022) Truong MT, Nwosu OB, Gaytan Torres ME, Segura Vargas MP, Seifer AK, Nitschke M, Ibrahim A, et al. Journal article CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH SYSTEMIC SCLEROSIS SINE SCLERODERMA: DATA FROM THE INTERNATIONAL EUSTAR DATABASE. (2022) Lescoat A, Huang S, Carreira P, Siegert E, De Vries-Bouwstra J, Distler J, Smith V, et al. Conference contribution GLUCOCORTICOIDS PRESCRIBING PRACTICES IN SYSTEMIC SCLEROSIS: AN ANALYSIS OF THE EUSTAR DATABASE. (2022) Iudici M, Mongin D, Siegert E, Carreira P, Distler J, Henes J, Zanatta E, et al. Conference contribution PERSISTENT INFLAMMATION IN SYSTEMIC SCLEROSIS IS STRONGLY ASSOCIATED WITH SEVERE DISEASE AND MORTALITY: AN ANALYSIS FROM THE EUSTAR DATABASE (2022) Sarbu AC, Guler S, Stadler O, Allanore Y, Bernardino V, Distler J, Gabrielli A, et al. Conference contribution ABATACEPT DELAYS THE DEVELOPMENT OF RA-CLINICAL RESULTS AFTER 18 MONTHS FROM THE RANDOMIZED, PLACEBO-CONTROLLED ARIAA STUDY IN RA-AT RISK PATIENTS (2022) Rech J, Kleyer A, Ostergaard M, Hagen M, Valor L, Tascilar K, Krönke G, et al. Conference contribution